Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gensia Sicor GenESA cardiac stress testing system launches Sept. 15

This article was originally published in The Gray Sheet

Executive Summary

GENSIA SICOR GENESA CARDIAC STRESS TESTING SYSTEM LAUNCH commences Sept. 15 to targeted cardiologists following approval Sept. 12 for use in the diagnosis of coronary artery disease in conjunction with radionuclide myocardial perfusion imaging and echocardiography for patients who cannot exercise adequately. The company currently has a 25-person sales force and has plans to add five more reps before year-end. Gensia predicts that its sales team will reach 40 by the end of 1998.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008757

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel